Developments Novan completes enrollment in pivotal Phase 3 molluscum contagiosum trial Novan (NASDAQ:NOVN) has completed patient enrollment in its Phase 3 pivotal trial of SB206, a topical antiviral gel, for the treatment of molluscum contagiosum. Molluscum contagiosum is a viral skin infection that... August 14, 2019